Advertisement

Control of Transmissible Diseases in Health Care Organizations

  • Andrew Kucharski
  • Robert Mittendorf
Chapter
  • 43 Downloads

Abstract

Epidemiology as a discipline had as its historical focus the investigation of epidemics. In the United States, the period between 1800 and 1875 was characterized by a number of great epidemics, in particular cholera, yellow fever, smallpox, and typhoid fever (Smillie, 1952). The epidemiologic thinking of that time was that an epidemic was the result of uncontrollable conditions, not spread from person to person. Several authors linked poverty, overcrowding, and bad social conditions to the great excess in mortality that occurred during the epidemics. Between the period of 1900 and 1980, a large decline in mortality from transmissible disease was observed. Improved nutrition, sanitation, and less crowded housing coupled with the advent of the use of antibiotics in 1940 contributed to this decline. However, since 1980, the incidence and mortality from transmissible diseases have been increasing for several reasons.

Keywords

Nosocomial Infection Health Care Worker Health Care Organization Protein Purify Derivative Health Care Manager 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. American Public Health Association, 1990, The Control of Communicable Diseases in Man, APHA, New York.Google Scholar
  2. Barnes, P. F., Bloch, A. B., Davidson, P. T., and Snider, D. E., 1991, Tuberculosis in patients with human immunodeficiency virus infection, N. Engl. J. Med. 234:1644–1650.Google Scholar
  3. Beck-Sague, C., Dooley, S. W., and Hutton, M. D., 1992, Outbreak of multidrug-resistant Mycobacterium tuberculosis infections in a hospital: Transmission to patients with HIV infection and staff, JAMA 268:1280–1286.PubMedCrossRefGoogle Scholar
  4. Bentley, D. W., and Cheney, L., 1990, Infection control in the nursing home: The physician’s role, Geriatrics 45:59–66.PubMedGoogle Scholar
  5. Centers for Disease Control, 1986, Tuberculosis and acquired immunodeficiency syndrome—Florida, Morbid. Mortal. Weekly Rep. 35:587–590.Google Scholar
  6. Centers for Disease Control, 1990, Protection against viral hepatitis: Recommendations of the Immunization Practices Advisory Committee (ACIP), Morbid. Mortal. Weekly Rep. 39:5–22.Google Scholar
  7. Centers for Disease Control, 1992, Prevention and control of tuberculosis in U.S. communities with at-risk minority populations: Recommendations of the Advisory Council for the Elimination of Tuberculosis, Morbid. Mortal. Weekly Rep. 41(no. RR-5):1–11.Google Scholar
  8. Centers for Disease Control, 1993, Tuberculosis morbidity—United States, 1992, Morbid. Mortal. Weekly Rep. 42:696–704.Google Scholar
  9. Crossley, K., Nelson, L., and Irvine, P., 1992, State regulations governing infection control issues in long-term care, J. Am. Geriatr. Soc. 40:251–254.PubMedGoogle Scholar
  10. Darnowski, S. B., Gordon, M., Simor, A. E., 1991, Two year study of infection surveillance in a geriatric long-term care facility, Am. J. Infect. Control 19 :185-190. PubMedCrossRefGoogle Scholar
  11. Edlin, B. R., Tokars, J. I., and Grieco, M. H., 1992, An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome, N. Engl. J. Med. 326:1514–1521.PubMedCrossRefGoogle Scholar
  12. Fine, P. E. M., 1993, Herd immunity: History, theory, practice, Epidemiol. Rev. 15:265–302.PubMedGoogle Scholar
  13. Haley, R. W., Schaberg, D. R., Crossley, K. B., von Allmen, S. D., and McGowan, J. E., 1981, Extra charges and prolongation of stay attributable to nosocomial infections: A prospective interhospital comparison, Am. J. Med. 70:51–58.PubMedCrossRefGoogle Scholar
  14. Haley, R., Culver, D. H., White, J. W., Morgan, W. M., Emori, T. G., Munn, V. P., and Hooton, T. M., 1985, The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals, Am. J. Epidemiol. 121:182–205.PubMedGoogle Scholar
  15. Horan, T. C., White, J. W., Jarvix, W. R., Emori, T. G., Culver, D. H., Munn, V. P., Thornsberry, C., Olson, D. R., and Hughes, J. M., 1986, Nosocomial infection surveillance, Morbid. Mortal. Weekly Rep. 35:17SS–29SS.Google Scholar
  16. Jawetz, E., Melnick, J. L., and Adelberg, E. A., 1991, Jawetz, Melnick and Adelberg’s Medical Microbiology, 19th ed.,Appleton & Lange, East Norwalk, CT.Google Scholar
  17. Moga, D. N., Brodeur, S. E., and Beckman, P., 1991, AIDS in the workplace: Implications for hospice programs, Hospice J. 7:151–169.CrossRefGoogle Scholar
  18. Mylotte, J. M., Karuza, J., and Bentley, D. W., 1992, Methicillin-resistant Staphylococcus aureus: A questionnaire survey of 75 long-term care facilities in western New York, Infect. Control Hosp. Epidemiol. 13:711–718.PubMedCrossRefGoogle Scholar
  19. Office of Technology Assessment, U.S. Congress, 1993, The continuing challenge of tuberculosis. OTA-H-574,U.S. Government Printing Office, Washington, DC.Google Scholar
  20. Shears, P., Rhodes, L. E., Syed, Q., and Watson, J., 1994, A pseudo outbreak of tuberculosis, Commun. Dis. Rep. CDR Rev. 4:R9–10.Google Scholar
  21. Smillie, W., 1952, The period of great epidemics in the United States (1800–1875), in The History of American Epidemiology (C. E. A. Winslow, eds.), C. V. Mosby, St. Louis.Google Scholar
  22. Stead, W. W., and Dutt, A. K., 1991, Tuberculosis in elderly persons, Annu. Rev. Med. 42:267–276.PubMedCrossRefGoogle Scholar
  23. Theuer, C. P., Hopewell, P. C., and Elias, D., 1990, Human immunodeficiency virus infection in tuberculosis patients, J. Infect. Dis. 162:8–12.PubMedCrossRefGoogle Scholar
  24. U.S. Department of Health and Human Services Centers for Disease Control and Prevention, 1994, DHHS Pub. No. (PHS94–1232), National Center for Health Statistics, Hyattsville, MD.Google Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Andrew Kucharski
    • 1
  • Robert Mittendorf
    • 2
  1. 1.Department of Clinical DevelopmentImmunex CorporationSeattleUSA
  2. 2.Department of Obstetrics and GynecologyUniversity of ChicagoChicagoUSA

Personalised recommendations